| Status | Study |
| Not yet recruiting |
Study Name: Examining the Knowledge, Attitudes, and Beliefs of Sickle Cell Disease Patients, Parents of Patients With Sickle Cell Disease, and Providers Towards the Integration of CRISPR in Clinical Care Condition: Sickle Cell Disease Date: 2017-05-24 |
| Not yet recruiting |
Study Name: Sleep and Pain in Sickle Cell Disease Condition: Sickle Cell Disease Sleep Disturbance Date: 2017-05-03 Interventions: Behavioral: Behavioral symptom management |
| Not yet recruiting |
Study Name: A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease Condition: Sickle Cell Disease Date: 2017-04-24 Interventions: Drug: INCB059872 INCB059872 at the protocol-defined dose administered QOD or QD based on cohort assignme |
| Recruiting |
Study Name: A Study to Compare if the Uptake of Ticagrelor in the Body Differs When Different Tablets Are Administered Condition: Sickle Cell Disease Date: 2017-04-20 Interventions: Drug: Ticagrelor granule A P2Y |
| Recruiting |
Study Name: Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease Condition: Sickle Cell Disease Date: 2017-04-14 Interventions: Drug: ATG 0.5 mg/kg IV on day |
| Recruiting |
Study Name: Monocytic Expression of Heme Oxidase-1 (HO-1) in Sickle Cell Patients and Correlation With the Humoral Immune Response to Vaccine and With Allo-immunization. Condition: Sickle Cell Disease Date: 2017-04-07 Interventions: Biological: Inactivated influenza A (H1N1) virus vaccine |
| Recruiting |
Study Name: Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders Condition: Severe Sickle Cell Disease Bone Marrow Failure Syndromes Date: 2017-04-03 Interventions: Drug: RIC regimen Days -60 to |
| Recruiting |
Study Name: Heart Arteries and Sickle Cell Disease / Coeur Artères DREpanocytose Condition: Sickle Cell Anemia Sickle Cell Disease Date: 2017-03-30 |
| Recruiting |
Study Name: Acute Kidney Injury in Patients With Sickle Cell Disease Condition: Sickle Cell Disease Kidney Injury Date: 2017-03-23 |
| Not yet recruiting |
Study Name: Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areas Condition: Sickle Cell Anemia Sickle Cell Disease Date: 2017-03-22 Interventions: Drug: Hydroxyurea Administered once a day in tablet form (100mg or scored 1000mg) for 24 months |